Whistleblower Helps DOJ Settle Biopharmaceutical Company False Claims Act Charges of False Commercial Billing Practices for $6.5 Million

The US District of Justice announced on April 6, 2020, that MiMedx Group Inc. (MiMedx) is based in Georgia made and sold human tissue grafts. The payment settles a claim brough by a whistleblower under the qui tam provisions of the False Claims act. The whistleblower was a sales representative. The False Claims Act per...

Attention Whistleblowers: CMS Clarifies the 60 Day Overpayment Rule which Drastically Affects False Claims Act Cases

Normally, whistleblowers that come into our office have identified an overpayment made by the government to their employer and the employer, most often, knowingly neglects to repay the amount.  The “60 Day Rule” as it is called was a part of Obama’s Affordable Care Act and implemented in March 23, 2010.  It req...